Modulation by caspases of tumor necrosis factor-stimulated c-Jun N-terminal kinase activation but not nuclear factor-kappa B signaling

A F Littlejohn, S J Tucker, A A A Mohamed, S McKay, M J Helms, P Vandenabeele, D J MacEwan

Research output: Contribution to journalArticle

Abstract

Tumour necrosis factor-alpha (TNF) is capable of activating many downstream signaling molecules via its two receptors TNFR1 and TNFR2. TNF can stimulate the proinflammatory transcription factor nuclear factor-kappaB (NF-kappaB) as well as the stress induced kinase c-Jun N-terminal kinase (JNK) through mechanisms that are not fully delineated. NF-kappaB becomes activated mainly through TNFR1 while JNK can be stimulated by either TNF receptor subtype. TNF can also induce apoptosis within cells due to its ability to recruit procaspase-8 to TNFR1, which in turn induces the caspase proteolytic cascade. We provide evidence here in human cells, that TNF-induced JNK activation is under the influence of caspases while NF-kappaB activity is not. By using pharmacological inhibitors of caspases, we have shown that JNK activity is reduced following caspase inhibition, especially when caspase-3 is targeted. NF-kappaB activity, as assessed by IkappaBalpha or IkappaBbeta degradation, electrophoretic mobility shift assay and NF-kappaB gene reporter assays, is shown to be unaffected by caspase inhibition. Therefore, downstream TNF receptor signaling events are differentially influenced by caspases. (C) 2002 Elsevier Science Inc. All rights reserved.

Original languageEnglish
Pages (from-to)91-99
Number of pages9
JournalBiochemical Pharmacology
Volume65
Publication statusPublished - 2003

Keywords

  • human
  • signal transduction
  • apoptosis
  • inflammation
  • cytokine receptors
  • transcription factor
  • SITE-SPECIFIC PHOSPHORYLATION
  • APOPTOTIC CELL-DEATH
  • TNF-RECEPTOR
  • ALPHA
  • PROTEIN
  • PATHWAY
  • DOMAIN
  • JNK
  • LIGAND
  • RIP

Cite this

Littlejohn, A. F., Tucker, S. J., Mohamed, A. A. A., McKay, S., Helms, M. J., Vandenabeele, P., & MacEwan, D. J. (2003). Modulation by caspases of tumor necrosis factor-stimulated c-Jun N-terminal kinase activation but not nuclear factor-kappa B signaling. Biochemical Pharmacology, 65, 91-99.

Modulation by caspases of tumor necrosis factor-stimulated c-Jun N-terminal kinase activation but not nuclear factor-kappa B signaling. / Littlejohn, A F ; Tucker, S J ; Mohamed, A A A ; McKay, S ; Helms, M J ; Vandenabeele, P ; MacEwan, D J .

In: Biochemical Pharmacology, Vol. 65, 2003, p. 91-99.

Research output: Contribution to journalArticle

Littlejohn, AF, Tucker, SJ, Mohamed, AAA, McKay, S, Helms, MJ, Vandenabeele, P & MacEwan, DJ 2003, 'Modulation by caspases of tumor necrosis factor-stimulated c-Jun N-terminal kinase activation but not nuclear factor-kappa B signaling', Biochemical Pharmacology, vol. 65, pp. 91-99.
Littlejohn, A F ; Tucker, S J ; Mohamed, A A A ; McKay, S ; Helms, M J ; Vandenabeele, P ; MacEwan, D J . / Modulation by caspases of tumor necrosis factor-stimulated c-Jun N-terminal kinase activation but not nuclear factor-kappa B signaling. In: Biochemical Pharmacology. 2003 ; Vol. 65. pp. 91-99.
@article{5aaa7da48d464c69be18f4bcfb61a5c9,
title = "Modulation by caspases of tumor necrosis factor-stimulated c-Jun N-terminal kinase activation but not nuclear factor-kappa B signaling",
abstract = "Tumour necrosis factor-alpha (TNF) is capable of activating many downstream signaling molecules via its two receptors TNFR1 and TNFR2. TNF can stimulate the proinflammatory transcription factor nuclear factor-kappaB (NF-kappaB) as well as the stress induced kinase c-Jun N-terminal kinase (JNK) through mechanisms that are not fully delineated. NF-kappaB becomes activated mainly through TNFR1 while JNK can be stimulated by either TNF receptor subtype. TNF can also induce apoptosis within cells due to its ability to recruit procaspase-8 to TNFR1, which in turn induces the caspase proteolytic cascade. We provide evidence here in human cells, that TNF-induced JNK activation is under the influence of caspases while NF-kappaB activity is not. By using pharmacological inhibitors of caspases, we have shown that JNK activity is reduced following caspase inhibition, especially when caspase-3 is targeted. NF-kappaB activity, as assessed by IkappaBalpha or IkappaBbeta degradation, electrophoretic mobility shift assay and NF-kappaB gene reporter assays, is shown to be unaffected by caspase inhibition. Therefore, downstream TNF receptor signaling events are differentially influenced by caspases. (C) 2002 Elsevier Science Inc. All rights reserved.",
keywords = "human, signal transduction, apoptosis, inflammation, cytokine receptors, transcription factor, SITE-SPECIFIC PHOSPHORYLATION, APOPTOTIC CELL-DEATH, TNF-RECEPTOR, ALPHA, PROTEIN, PATHWAY, DOMAIN, JNK, LIGAND, RIP",
author = "Littlejohn, {A F} and Tucker, {S J} and Mohamed, {A A A} and S McKay and Helms, {M J} and P Vandenabeele and MacEwan, {D J}",
year = "2003",
language = "English",
volume = "65",
pages = "91--99",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Modulation by caspases of tumor necrosis factor-stimulated c-Jun N-terminal kinase activation but not nuclear factor-kappa B signaling

AU - Littlejohn, A F

AU - Tucker, S J

AU - Mohamed, A A A

AU - McKay, S

AU - Helms, M J

AU - Vandenabeele, P

AU - MacEwan, D J

PY - 2003

Y1 - 2003

N2 - Tumour necrosis factor-alpha (TNF) is capable of activating many downstream signaling molecules via its two receptors TNFR1 and TNFR2. TNF can stimulate the proinflammatory transcription factor nuclear factor-kappaB (NF-kappaB) as well as the stress induced kinase c-Jun N-terminal kinase (JNK) through mechanisms that are not fully delineated. NF-kappaB becomes activated mainly through TNFR1 while JNK can be stimulated by either TNF receptor subtype. TNF can also induce apoptosis within cells due to its ability to recruit procaspase-8 to TNFR1, which in turn induces the caspase proteolytic cascade. We provide evidence here in human cells, that TNF-induced JNK activation is under the influence of caspases while NF-kappaB activity is not. By using pharmacological inhibitors of caspases, we have shown that JNK activity is reduced following caspase inhibition, especially when caspase-3 is targeted. NF-kappaB activity, as assessed by IkappaBalpha or IkappaBbeta degradation, electrophoretic mobility shift assay and NF-kappaB gene reporter assays, is shown to be unaffected by caspase inhibition. Therefore, downstream TNF receptor signaling events are differentially influenced by caspases. (C) 2002 Elsevier Science Inc. All rights reserved.

AB - Tumour necrosis factor-alpha (TNF) is capable of activating many downstream signaling molecules via its two receptors TNFR1 and TNFR2. TNF can stimulate the proinflammatory transcription factor nuclear factor-kappaB (NF-kappaB) as well as the stress induced kinase c-Jun N-terminal kinase (JNK) through mechanisms that are not fully delineated. NF-kappaB becomes activated mainly through TNFR1 while JNK can be stimulated by either TNF receptor subtype. TNF can also induce apoptosis within cells due to its ability to recruit procaspase-8 to TNFR1, which in turn induces the caspase proteolytic cascade. We provide evidence here in human cells, that TNF-induced JNK activation is under the influence of caspases while NF-kappaB activity is not. By using pharmacological inhibitors of caspases, we have shown that JNK activity is reduced following caspase inhibition, especially when caspase-3 is targeted. NF-kappaB activity, as assessed by IkappaBalpha or IkappaBbeta degradation, electrophoretic mobility shift assay and NF-kappaB gene reporter assays, is shown to be unaffected by caspase inhibition. Therefore, downstream TNF receptor signaling events are differentially influenced by caspases. (C) 2002 Elsevier Science Inc. All rights reserved.

KW - human

KW - signal transduction

KW - apoptosis

KW - inflammation

KW - cytokine receptors

KW - transcription factor

KW - SITE-SPECIFIC PHOSPHORYLATION

KW - APOPTOTIC CELL-DEATH

KW - TNF-RECEPTOR

KW - ALPHA

KW - PROTEIN

KW - PATHWAY

KW - DOMAIN

KW - JNK

KW - LIGAND

KW - RIP

M3 - Article

VL - 65

SP - 91

EP - 99

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

ER -